Immune Therapeutics, Inc.
IMUN
Other OTC0.09
USD
-0.01
- -
Total Valuation
Immune Therapeutics, Inc. carries a market capitalization of 7.78M, placing it among publicly traded companies globally.
| Market Cap | 7.78M |
| Enterprise Value | N/A |
Stock Price Statistics
Immune Therapeutics, Inc.'s stock has declined approximately -91.14286% over the past 52 weeks. The 50-day moving average sits at 0.20, while the 200-day moving average is 0.48.
| Beta (5Y) | N/A |
| 52-Week Price Change | -91.14286% |
| 50-Day Moving Average | 0.20 |
| 200-Day Moving Average | 0.48 |
| Average Volume (20 Days) | N/A |
Stock Splits
Immune Therapeutics, Inc.'s most recent stock split took place on May 6, 2021 with a 1000:1 split ratio.
| Last Split Date | 5/6/2021 |
| Split Ratio | 1000:1 |